The current valuation score of MannKind Corp is 4.66, ranking 368 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -50.07, which is -470.70% below the recent high of 185.61 and -135.41% above the recent low of -117.87.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.